Zespół nadpobudliwości psychoruchowej z deficytem uwagi (adhd)
Rokowania, prognozy i postęp choroby

Zespół nadpobudliwości psychoruchowej z deficytem uwagi (ADHD) wykazuje wysoką przewlekłość, z około 15% dzieci utrzymujących pełnoobjawowy zespół do 25. roku życia oraz 65% z rezydualnymi objawami upośledzającymi funkcjonowanie. Czynniki prognostyczne obejmują nasilenie objawów i upośledzenie funkcjonowania w dzieciństwie, współwystępujące zaburzenia (CD, ODD, zaburzenia nastroju i lękowe), IQ, słabe funkcjonowanie szkolne i społeczne, a także konflikty rodzinne i typ mieszany ADHD. Wczesna odpowiedź na leczenie metylfenidatem (redukcja objawów o 20-40% w 3. i 12. tygodniu) jest istotnym predyktorem lepszego długoterminowego wyniku objawów, choć predyktory efektu farmakologicznego pozostają niejednoznaczne. Modele predykcyjne oparte na funkcjach poznawczych i cechach demograficznych wyjaśniają 12-20% wariancji objawów w krótkim okresie obserwacji.

Prognoza ogólna w ADHD u dzieci i młodzieży

Zespół nadpobudliwości psychoruchowej z deficytem uwagi (ADHD) często utrzymuje się przez całe życie, istnieją jednak określone czynniki, które mogą wskazywać na rokowanie. Według aktualnych danych, około 1/3 dzieci z ADHD wykazuje remisję objawów w wieku dorosłym, natomiast pozostali pacjenci nadal mają pełnoobjawowy zespół lub znaczące objawy, które nie spełniają wszystkich kryteriów diagnostycznych.1 Najnowsza metaanaliza prospektywnych badań długoterminowych szacuje, że wskaźnik utrzymywania się ADHD jako pełnego zespołu do 25. roku życia wynosi około 15%, natomiast utrzymywanie się rezydualnych, upośledzających funkcjonowanie objawów w tym wieku sięga 65%.2 Inne badania sugerują, że około 79% pacjentów z dzieciństwa nadal spełnia kliniczne kryteria ADHD w okresie dojrzewania i wczesnej dorosłości.3

ADHD wiąże się ze znaczącymi niekorzystnymi konsekwencjami w dzieciństwie i okresie dojrzewania, takimi jak: problemy edukacyjne (skutkujące niskim wskaźnikiem ukończenia szkoły średniej i edukacji pomaturalnej), trudne relacje rówieśnicze, zwiększone ryzyko wypadków komunikacyjnych, przypadkowych urazów oraz nadużywania substancji psychoaktywnych. Ryzyko nadużywania substancji zwiększa się dodatkowo, gdy ADHD współwystępuje z zaburzeniami zachowania. Obecność tych współwystępujących stanów i ADHD jest powiązana ze zwiększonym ryzykiem śmiertelności.4 Objawy ADHD w młodym wieku są również powiązane z wieloma innymi negatywnymi skutkami, w tym gorszymi osiągnięciami akademickimi, używaniem substancji psychoaktywnych, zaburzeniami eksternalizacyjnymi oraz długotrwałymi trudnościami finansowymi.5

Czynniki predykcyjne utrzymywania się ADHD

Istnieje kilka dobrze zidentyfikowanych czynników predykcyjnych utrzymywania się ADHD z dzieciństwa do okresu dojrzewania i dorosłości. Kluczowe czynniki rokujące obejmują:67

  • Nasilenie i upośledzenie funkcjonowania z powodu ADHD w dzieciństwie
  • Współwystępujące zaburzenia w dzieciństwie (CD, ODD, zaburzenia nastroju i lękowe)
  • IQ
  • Słabe funkcjonowanie szkolne i społeczne
  • Problemy behawioralne
  • Psychopatologia i konflikty rodzicielskie
  • Występowanie typu mieszanego zaburzenia (z objawami nieuwagi i nadpobudliwości)
  • Lęk u rodziców
  • Antyspołeczne zaburzenia osobowości u rodziców

89

Wyższe nasilenie objawów ADHD ocenianych przez rodziców oraz intensywność ruchowa mierzona aktygrafią w dzieciństwie prognozują większe nasilenie objawów ADHD w późniejszym okresie. Co interesujące, oceny objawów przez nauczycieli nie mają tak istotnej wartości predykcyjnej.10 Status socjoekonomiczny (SES) i IQ ujawniają się jako potencjalne moderatory prognozy ADHD.11

Predykcja rozwojowa w różnych okresach życia

Prezentacja ADHD i związane z nim zaburzenia ewoluują w trakcie rozwoju, podobnie jak czynniki prognostyczne. W rozwoju wczesnodziecięcym, oprócz czynników genetycznych, niektóre formy niekorzystnych warunków prenatalnych zwiększają ryzyko wystąpienia ADHD. W wieku przedszkolnym nasilenie objawów, funkcje poznawcze i czynniki rodzinne stają się istotnymi predyktorami wyników w wieku szkolnym. Te same czynniki nadal prognozują długoterminowe wyniki u dzieci w wieku szkolnym, a współchorobowość wyłania się jako kolejny istotny długoterminowy czynnik predykcyjny na tym etapie.12

Funkcjonalne wyniki długoterminowe

Jeśli chodzi o funkcjonalne wyniki u dorosłych, być może najważniejszym czynnikiem determinującym jest utrzymywanie się ADHD. Dorośli z utrzymującym się ADHD wykazują większe upośledzenie w głównych obszarach życia, takich jak praca zawodowa, edukacja, obowiązki domowe, związki romantyczne, funkcjonowanie społeczne i aktywności społeczne, a także mają wyższe wskaźniki współchorobowości niż osoby uznane za będące w remisji.13 Co istotne, osoby z remisją ADHD były nieodróżnialne od grupy kontrolnej w tych obszarach.14

Nasilenie ADHD w dzieciństwie i okresie dojrzewania jest kolejnym czynnikiem, który według doniesień przewiduje upośledzenie funkcjonowania dorosłych w wyżej wymienionych głównych domenach życia.15 Współchorobowość w dzieciństwie przewiduje również współchorobowość w późniejszym życiu.16

Funkcje poznawcze jako predyktory

Badania wykazały, że modele predykcyjne wykorzystujące zdolności poznawcze, dane demograficzne oraz charakterystykę dziecka i rodziny mogą wyjaśnić 15-20% wariancji objawów ADHD w okresie jednorocznym i 12-13% wariancji objawów w okresie dwuletnim.17 Funkcje poznawcze odpowiadają za około 4% wariancji ponad inne domeny i są istotnym elementem oszczędnych modeli predykcyjnych, które osiągają porównywalną skuteczność do bardziej złożonych modeli.18

Sukces takiego oszczędnego modelu może okazać się szczególnie istotny dla predykcji w warunkach stosowanych, zmniejszając liczbę potrzebnych pomiarów.19 Badania wykazały, że modele uczenia maszynowego mogą skutecznie wykorzystywać informacje o funkcjach poznawczych i innych cechach młodzieży, w tym płci, samoocenianej impulsywności i czasie spędzanym przed ekranem, do generowania prognoz dotyczących objawów ADHD u dzieci, które uogólniają się na niewidoczne dane z różnych próbek.20

Predykcja odpowiedzi na leczenie

Odpowiedź na metylofenidat jako predyktor

Wczesna odpowiedź na leczenie może być istotnym predyktorem długoterminowych wyników. Badania wykazały, że odpowiedź na leczenie metylfenidatem w 3. i 12. tygodniu była istotnym predyktorem długoterminowego wyniku objawów, ale nie upośledzenia funkcjonowania w 3-letniej obserwacji, po skorygowaniu o inne znane predyktory.21 Pozytywna odpowiedź na leczenie metylfenidatem 3 i 12 tygodni po rozpoczęciu, mierzona odpowiednio jako 20% lub 40% redukcja objawów, znacząco przewidywała mniejszą nadpobudliwość/impulsywność oraz objawy opozycyjno-buntownicze w 3-letniej obserwacji, ponad wyjściowe objawy i upośledzenie, współchorobowość i inne znane predyktory.22

Wyniki sugerują, że klinicyści muszą oceniać i leczyć osoby, które nie reagują na leki stosowane w ADHD w ciągu pierwszych miesięcy leczenia, ze zwiększonym wysiłkiem, ponieważ mają one gorsze długoterminowe rokowanie, a gorsze rokowanie było tylko częściowo wyjaśnione przez współwystępującą psychopatologię i inne znane predyktory.23 Ta 3-letnia obserwacja klinicznej kohorty dzieci z ADHD, bez informacji o przestrzeganiu zaleceń dotyczących leków na ADHD po 3 miesiącach, pokazuje, że wczesna odpowiedź na leczenie w 3 i 12 tygodniu przewiduje lepszy długoterminowy wynik.24

Przewidywanie skuteczności leków

Pomimo obiecujących wyników dotyczących znaczenia wczesnej odpowiedzi na leczenie, predyktory efektu farmakologicznego leków stosowanych w ADHD u dzieci i młodzieży nadal są niejednoznaczne. W dużym (N=638) prospektywnym badaniu kohortowym odzwierciedlającym rzeczywiste dowody nie zidentyfikowano żadnych istotnych klinicznie czynników, które niezawodnie przewidywałyby wyniki leczenia farmakologicznego.25 Wyniki te potwierdzają zgromadzone dowody, że do tej pory nie ujawniono wyraźnych predyktorów efektu leczenia farmakologicznego ADHD.26

Ustalenia dotyczące tego, czy leczenie stymulantami wpływa na wyniki, są niejednoznaczne.27 W świetle tych okoliczności, rozsądne jest rozważenie nowej perspektywy dotyczącej tego, które dziecko skorzystałoby najbardziej z farmakologicznego leczenia ADHD.28

Współchorobowość i przyszłe ryzyko

Dzieci z cechami neuroróżnorodności w wieku 7 i 9 lat miały dwukrotnie większe prawdopodobieństwo doświadczenia przewlekłego, upośledzającego zmęczenia w wieku 18 lat (prawdopodobne ADHD OR=2,18 (95% CI=1,33 do 3,56); p=0,002; prawdopodobny autyzm OR=1,78 (95% CI=1,17 do 2,72); p=0,004).29 Dzieci, które spełniały kryteria prawdopodobnego autyzmu lub ADHD, wykazywały większą częstość przewlekłego, upośledzającego zmęczenia w wieku 18 lat w porównaniu z dziećmi, które nie spełniały tych kryteriów.30

Zwiększony stan zapalny, wskazywany przez poziomy IL-6 w wieku 9 lat, stanowi potencjalne mechanistyczne wyjaśnienie tego związku, nawet po uwzględnieniu depresji.31 Wyniki te wskazują na wyższe ryzyko przewlekłego, upośledzającego zmęczenia u dzieci z cechami neuroróżnorodności, prawdopodobnie związanego z wyższym poziomem stanu zapalnego.32 Ustalenia te wskazują na potrzebę transdiagnostycznych praktyk przesiewowych w celu wspierania zdrowia i dobrego samopoczucia podczas rozwoju i okresu dojrzewania.33

Implikacje kliniczne

Ponieważ ADHD jest zaburzeniem heterogenicznym, a pediatrzy i lekarze rodzinni są pierwszymi świadczeniodawcami przeprowadzającymi ocenę medyczną dzieci i młodzieży z ADHD, ich szkolenie powinno wyposażyć ich w umiejętności kliniczne niezbędne do oceny i zarządzania ADHD oraz współistniejącymi zaburzeniami.34 Czynniki takie jak nasilenie objawów ADHD w dzieciństwie, mierzone oceną rodzicielską i intensywnością ruchu w aktygrafii, powinny być brane pod uwagę przy identyfikacji dzieci z ADHD najbardziej zagrożonych złymi długoterminowymi wynikami oraz przy opracowywaniu interwencji mających na celu poprawę rokowania.35

Badania zidentyfikowały predyktory utrzymywania się ADHD i wyników funkcjonalnych na różnych etapach rozwojowych.36 Jako stan trwający całe życie, ADHD może wymagać ciągłego leczenia w celu promowania optymalnych długoterminowych wyników.37 Prezentacja ADHD i czynniki ryzyka późniejszych niekorzystnych następstw ewoluują w trakcie rozwoju, co wymaga praktyk klinicznych uwzględniających rozwój.38

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    Overall, these studies have suggested that roughly 1/3 of children with ADHD show remission by adulthood, while the rest continue to have either the full syndrome or significant symptoms that fall short of the diagnostic criteria. […] The most recent meta-analysis of prospective long-term follow up studies estimated that the rate of persistence of ADHD as a syndrome by age 25 is 15%, but the rate of persistence of residual impairing symptoms by this age is 65%. […] The factors predicting persistence of childhood ADHD into adolescence and adulthood have included: severity of and impairment from childhood ADHD; comorbid childhood CD, ODD, mood, and anxiety disorders; IQ; poor school and social functioning and behavioral problems; and parental psychopathology and conflict. […] In terms of functional adult outcomes, perhaps the most important determinant is persistence of ADHD. As adults, those with persisting ADHD showed more impairment in major life domains, such as occupation, education, home responsibilities, romantic relationships, social functioning, and community activities, and had higher comorbidity rates than those considered in remission.
  • #2 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    Overall, these studies have suggested that roughly 1/3 of children with ADHD show remission by adulthood, while the rest continue to have either the full syndrome or significant symptoms that fall short of the diagnostic criteria. […] The most recent meta-analysis of prospective long-term follow up studies estimated that the rate of persistence of ADHD as a syndrome by age 25 is 15%, but the rate of persistence of residual impairing symptoms by this age is 65%. […] The factors predicting persistence of childhood ADHD into adolescence and adulthood have included: severity of and impairment from childhood ADHD; comorbid childhood CD, ODD, mood, and anxiety disorders; IQ; poor school and social functioning and behavioral problems; and parental psychopathology and conflict. […] In terms of functional adult outcomes, perhaps the most important determinant is persistence of ADHD. As adults, those with persisting ADHD showed more impairment in major life domains, such as occupation, education, home responsibilities, romantic relationships, social functioning, and community activities, and had higher comorbidity rates than those considered in remission.
  • #3 Childhood predictors of adolescent and young adult outcome in ADHD – PubMed
    https://pubmed.ncbi.nlm.nih.gov/25680235/
    Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood, but it remains unclear which childhood factors predict future outcome. […] To identify childhood predictors of ADHD outcome using both dimensional and categorical approaches. […] Of the sample, 79% continued to meet clinical criteria of ADHD in adolescence and young adulthood. Higher parent-rated ADHD symptoms and movement intensity in childhood, but not teacher-rated symptoms, predicted ADHD symptoms at follow up. […] SES and IQ emerge as potential moderators for the prognosis of ADHD. Childhood severity of ADHD symptoms, as measured by parent ratings and actigraph movement intensity, also predicts later ADHD outcome. These factors should be considered when identifying ADHD children at most risk of poor long-term outcomes and for the development of interventions to improve prognosis.
  • #4 ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity | Canadian Paediatric Society
    https://cps.ca/documents/position/adhd-etiology-diagnosis-and-comorbidity
    ADHD is associated with significant adverse outcomes in childhood and adolescence: educational problems (resulting in low rates of high-school graduation and completion of postsecondary education), difficult peer relationships and increased rates of motor vehicle accidents, accidental injuries, and substance misuse. Risk for substance abuse increases further when ADHD is comorbid with conduct disorder. The presence of these comorbid conditions and ADHD is associated with increased mortality risk. […] Current estimates show that 50% of children with ADHD continue to have symptoms of ADHD in adolescence and adulthood. Predictors of persistence include combined inattention/hyperactivity, increased symptom severity, comorbid major depressive or other mood disorder, high comorbidity (3 additional DSM disorders), parental anxiety, and parental antisocial personality disorder.
  • #5 Generalizable prediction of childhood ADHD symptoms from neurocognitive testing and youth characteristics | Translational Psychiatry
    https://www.nature.com/articles/s41398-023-02502-6
    ADHD symptoms in youth have been linked to many negative outcomes, including poorer academic achievement, substance use and externalizing behavior, and persistent financial difficulties. […] However, the evidence base for such measures is mixed. […] Current evidence for the relevance of neurocognitive performance to childhood ADHD symptoms exhibits several serious gaps. […] Our findings are significant for addressing the longstanding debate on the clinical and practical utility of neurocognitive abilities for predicting ADHD symptoms. […] Neurocognition accounted for roughly 4% of the variance beyond other domains and was featured heavily in a sparse predictive model that achieved comparable performance to more complex models. […] Our findings suggest neurocognitive features could meaningfully improve the prediction of childhood ADHD symptoms at the level of large systems.
  • #6 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    Overall, these studies have suggested that roughly 1/3 of children with ADHD show remission by adulthood, while the rest continue to have either the full syndrome or significant symptoms that fall short of the diagnostic criteria. […] The most recent meta-analysis of prospective long-term follow up studies estimated that the rate of persistence of ADHD as a syndrome by age 25 is 15%, but the rate of persistence of residual impairing symptoms by this age is 65%. […] The factors predicting persistence of childhood ADHD into adolescence and adulthood have included: severity of and impairment from childhood ADHD; comorbid childhood CD, ODD, mood, and anxiety disorders; IQ; poor school and social functioning and behavioral problems; and parental psychopathology and conflict. […] In terms of functional adult outcomes, perhaps the most important determinant is persistence of ADHD. As adults, those with persisting ADHD showed more impairment in major life domains, such as occupation, education, home responsibilities, romantic relationships, social functioning, and community activities, and had higher comorbidity rates than those considered in remission.
  • #7 ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity | Canadian Paediatric Society
    https://cps.ca/documents/position/adhd-etiology-diagnosis-and-comorbidity
    ADHD is associated with significant adverse outcomes in childhood and adolescence: educational problems (resulting in low rates of high-school graduation and completion of postsecondary education), difficult peer relationships and increased rates of motor vehicle accidents, accidental injuries, and substance misuse. Risk for substance abuse increases further when ADHD is comorbid with conduct disorder. The presence of these comorbid conditions and ADHD is associated with increased mortality risk. […] Current estimates show that 50% of children with ADHD continue to have symptoms of ADHD in adolescence and adulthood. Predictors of persistence include combined inattention/hyperactivity, increased symptom severity, comorbid major depressive or other mood disorder, high comorbidity (3 additional DSM disorders), parental anxiety, and parental antisocial personality disorder.
  • #8 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    Overall, these studies have suggested that roughly 1/3 of children with ADHD show remission by adulthood, while the rest continue to have either the full syndrome or significant symptoms that fall short of the diagnostic criteria. […] The most recent meta-analysis of prospective long-term follow up studies estimated that the rate of persistence of ADHD as a syndrome by age 25 is 15%, but the rate of persistence of residual impairing symptoms by this age is 65%. […] The factors predicting persistence of childhood ADHD into adolescence and adulthood have included: severity of and impairment from childhood ADHD; comorbid childhood CD, ODD, mood, and anxiety disorders; IQ; poor school and social functioning and behavioral problems; and parental psychopathology and conflict. […] In terms of functional adult outcomes, perhaps the most important determinant is persistence of ADHD. As adults, those with persisting ADHD showed more impairment in major life domains, such as occupation, education, home responsibilities, romantic relationships, social functioning, and community activities, and had higher comorbidity rates than those considered in remission.
  • #9 ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity | Canadian Paediatric Society
    https://cps.ca/documents/position/adhd-etiology-diagnosis-and-comorbidity
    ADHD is associated with significant adverse outcomes in childhood and adolescence: educational problems (resulting in low rates of high-school graduation and completion of postsecondary education), difficult peer relationships and increased rates of motor vehicle accidents, accidental injuries, and substance misuse. Risk for substance abuse increases further when ADHD is comorbid with conduct disorder. The presence of these comorbid conditions and ADHD is associated with increased mortality risk. […] Current estimates show that 50% of children with ADHD continue to have symptoms of ADHD in adolescence and adulthood. Predictors of persistence include combined inattention/hyperactivity, increased symptom severity, comorbid major depressive or other mood disorder, high comorbidity (3 additional DSM disorders), parental anxiety, and parental antisocial personality disorder.
  • #10 Childhood predictors of adolescent and young adult outcome in ADHD – PubMed
    https://pubmed.ncbi.nlm.nih.gov/25680235/
    Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood, but it remains unclear which childhood factors predict future outcome. […] To identify childhood predictors of ADHD outcome using both dimensional and categorical approaches. […] Of the sample, 79% continued to meet clinical criteria of ADHD in adolescence and young adulthood. Higher parent-rated ADHD symptoms and movement intensity in childhood, but not teacher-rated symptoms, predicted ADHD symptoms at follow up. […] SES and IQ emerge as potential moderators for the prognosis of ADHD. Childhood severity of ADHD symptoms, as measured by parent ratings and actigraph movement intensity, also predicts later ADHD outcome. These factors should be considered when identifying ADHD children at most risk of poor long-term outcomes and for the development of interventions to improve prognosis.
  • #11 Childhood predictors of adolescent and young adult outcome in ADHD – PubMed
    https://pubmed.ncbi.nlm.nih.gov/25680235/
    Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood, but it remains unclear which childhood factors predict future outcome. […] To identify childhood predictors of ADHD outcome using both dimensional and categorical approaches. […] Of the sample, 79% continued to meet clinical criteria of ADHD in adolescence and young adulthood. Higher parent-rated ADHD symptoms and movement intensity in childhood, but not teacher-rated symptoms, predicted ADHD symptoms at follow up. […] SES and IQ emerge as potential moderators for the prognosis of ADHD. Childhood severity of ADHD symptoms, as measured by parent ratings and actigraph movement intensity, also predicts later ADHD outcome. These factors should be considered when identifying ADHD children at most risk of poor long-term outcomes and for the development of interventions to improve prognosis.
  • #12 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    To outline the key features of the developmental progression of ADHD and to consider the most prominent influences on its developmental course and outcomes. […] Presentation of ADHD and associated impairments evolve across development, as do outcome predictors. In early development, in addition to genetics, some forms of prenatal adversity increase the risk for ADHD. In preschool years, symptom severity, cognitive function, and family factors become significant predictors of school age outcomes. These continue to predict long-term outcomes in school aged children, and comorbidity emerges as another significant long-term outcome predictor at this stage. […] Presentation of ADHD and risk factors for later adversity evolve across development, which calls for developmentally-informed clinical practices.
  • #13 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    Overall, these studies have suggested that roughly 1/3 of children with ADHD show remission by adulthood, while the rest continue to have either the full syndrome or significant symptoms that fall short of the diagnostic criteria. […] The most recent meta-analysis of prospective long-term follow up studies estimated that the rate of persistence of ADHD as a syndrome by age 25 is 15%, but the rate of persistence of residual impairing symptoms by this age is 65%. […] The factors predicting persistence of childhood ADHD into adolescence and adulthood have included: severity of and impairment from childhood ADHD; comorbid childhood CD, ODD, mood, and anxiety disorders; IQ; poor school and social functioning and behavioral problems; and parental psychopathology and conflict. […] In terms of functional adult outcomes, perhaps the most important determinant is persistence of ADHD. As adults, those with persisting ADHD showed more impairment in major life domains, such as occupation, education, home responsibilities, romantic relationships, social functioning, and community activities, and had higher comorbidity rates than those considered in remission.
  • #14 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    The latter were indistinguishable from controls in these areas. […] Severity of childhood and adolescent ADHD is another factor that has been reported to predict adult impairment in the above major life domains. […] Comorbidity in childhood predicts comorbidity in later life. […] Findings are equivocal as to whether stimulant treatment impacts outcomes. […] Research has identified predictors of ADHD persistence and functional outcomes at different developmental stages. […] As a lifelong condition, ADHD may require ongoing treatment to promote optimal long-term outcome.
  • #15 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    The latter were indistinguishable from controls in these areas. […] Severity of childhood and adolescent ADHD is another factor that has been reported to predict adult impairment in the above major life domains. […] Comorbidity in childhood predicts comorbidity in later life. […] Findings are equivocal as to whether stimulant treatment impacts outcomes. […] Research has identified predictors of ADHD persistence and functional outcomes at different developmental stages. […] As a lifelong condition, ADHD may require ongoing treatment to promote optimal long-term outcome.
  • #16 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    The latter were indistinguishable from controls in these areas. […] Severity of childhood and adolescent ADHD is another factor that has been reported to predict adult impairment in the above major life domains. […] Comorbidity in childhood predicts comorbidity in later life. […] Findings are equivocal as to whether stimulant treatment impacts outcomes. […] Research has identified predictors of ADHD persistence and functional outcomes at different developmental stages. […] As a lifelong condition, ADHD may require ongoing treatment to promote optimal long-term outcome.
  • #17 Generalizable prediction of childhood ADHD symptoms from neurocognitive testing and youth characteristics | Translational Psychiatry
    https://www.nature.com/articles/s41398-023-02502-6
    Childhood attention-deficit/hyperactivity disorder (ADHD) symptoms are believed to result from disrupted neurocognitive development. […] Using data drawn from the Adolescent Brain Cognitive Development Study (ABCD), we develop and test cross-validated machine learning models for predicting youths ADHD symptoms using neurocognitive abilities, demographics, and child and family characteristics. […] Predictive models explained 15-20% of the variance in 1-year ADHD symptoms for ABCD Study sites that were left out of the model-fitting process and 12-13% of the variance in 2-year ADHD symptoms. […] This work quantifies the information value of neurocognitive abilities and other child characteristics for predicting ADHD symptoms and provides a foundational method for predicting individual youths symptoms in new data across contexts.
  • #18 Generalizable prediction of childhood ADHD symptoms from neurocognitive testing and youth characteristics | Translational Psychiatry
    https://www.nature.com/articles/s41398-023-02502-6
    ADHD symptoms in youth have been linked to many negative outcomes, including poorer academic achievement, substance use and externalizing behavior, and persistent financial difficulties. […] However, the evidence base for such measures is mixed. […] Current evidence for the relevance of neurocognitive performance to childhood ADHD symptoms exhibits several serious gaps. […] Our findings are significant for addressing the longstanding debate on the clinical and practical utility of neurocognitive abilities for predicting ADHD symptoms. […] Neurocognition accounted for roughly 4% of the variance beyond other domains and was featured heavily in a sparse predictive model that achieved comparable performance to more complex models. […] Our findings suggest neurocognitive features could meaningfully improve the prediction of childhood ADHD symptoms at the level of large systems.
  • #19 Generalizable prediction of childhood ADHD symptoms from neurocognitive testing and youth characteristics | Translational Psychiatry
    https://www.nature.com/articles/s41398-023-02502-6
    The success of such a parsimonious model may prove particularly relevant for prediction in applied settings by reducing the number of measures needed. […] Predicting the difference between two highly correlated measures of the same trait is inherently challenging because much of the systematic variance in the individual measures is reflected in their correlation. […] This study demonstrates that machine learning models can effectively utilize information about neurocognition and other youth characteristics, including sex, self-reported impulsivity, and screen time, to generate predictions about childhood ADHD symptoms that generalize to unseen data from diverse samples.
  • #20 Generalizable prediction of childhood ADHD symptoms from neurocognitive testing and youth characteristics | Translational Psychiatry
    https://www.nature.com/articles/s41398-023-02502-6
    The success of such a parsimonious model may prove particularly relevant for prediction in applied settings by reducing the number of measures needed. […] Predicting the difference between two highly correlated measures of the same trait is inherently challenging because much of the systematic variance in the individual measures is reflected in their correlation. […] This study demonstrates that machine learning models can effectively utilize information about neurocognition and other youth characteristics, including sex, self-reported impulsivity, and screen time, to generate predictions about childhood ADHD symptoms that generalize to unseen data from diverse samples.
  • #21
    https://link.springer.com/article/10.1007/s00787-023-02158-z
    This study investigates early onset of treatment response as predictor of symptomatic and functional outcome 3 years after initiation of methylphenidate (MPH) administration in a naturalistic, clinical cohort of children and adolescents with ADHD. […] Treatment responses in week 3 and week 12 were significant predictors of the long-term outcome of symptoms, but not of impairment at 3-year follow-up, when adjusting for other well-known predictors. Early treatment response predicts long-term outcome over and above other well-known predictors. […] In summary, positive response to MPH treatment 3 and 12 weeks after initiation, measured respectively as a 20% or 40% reduction in symptoms, significantly predicted less hyperactivity/impulsivity and oppositional defiant symptoms at 3-year follow-up, over and above baseline symptoms and impairment, comorbidity, and other well-known predictors.
  • #22
    https://link.springer.com/article/10.1007/s00787-023-02158-z
    This study investigates early onset of treatment response as predictor of symptomatic and functional outcome 3 years after initiation of methylphenidate (MPH) administration in a naturalistic, clinical cohort of children and adolescents with ADHD. […] Treatment responses in week 3 and week 12 were significant predictors of the long-term outcome of symptoms, but not of impairment at 3-year follow-up, when adjusting for other well-known predictors. Early treatment response predicts long-term outcome over and above other well-known predictors. […] In summary, positive response to MPH treatment 3 and 12 weeks after initiation, measured respectively as a 20% or 40% reduction in symptoms, significantly predicted less hyperactivity/impulsivity and oppositional defiant symptoms at 3-year follow-up, over and above baseline symptoms and impairment, comorbidity, and other well-known predictors.
  • #23
    https://link.springer.com/article/10.1007/s00787-023-02158-z
    Our results indicate that clinicians must assess and treat those who do not respond to ADHD medication during the first months of treatment with bigger efforts, since they have a worse long-term prognosis, and the poorer prognosis was only partly explained by psychiatric comorbidity and other well-known predictors. […] This 3-year follow-up of a clinical cohort of children with ADHD, without information of adherence to ADHD medication beyond 3 months, demonstrates that early treatment response at 3 and 12 weeks predicts a better long-term outcome.
  • #24
    https://link.springer.com/article/10.1007/s00787-023-02158-z
    Our results indicate that clinicians must assess and treat those who do not respond to ADHD medication during the first months of treatment with bigger efforts, since they have a worse long-term prognosis, and the poorer prognosis was only partly explained by psychiatric comorbidity and other well-known predictors. […] This 3-year follow-up of a clinical cohort of children with ADHD, without information of adherence to ADHD medication beyond 3 months, demonstrates that early treatment response at 3 and 12 weeks predicts a better long-term outcome.
  • #25
    https://link.springer.com/article/10.1007/s00787-025-02650-8
    Predictors for the pharmacological effect of ADHD medication in children and adolescents are lacking. This study examined clinically relevant factors in a large (N=638) prospective cohort reflecting real-world evidence. […] In our large naturalistic cohort, we could not identify any clinically relevant factors that reliably predict pharmacological treatment outcomes. […] Our findings support the compiled evidence that to date, distinct predictors for the treatment effect of ADHD medication have not yet been revealed. […] Given these circumstances, it is reasonable to consider a new perspective regarding which child would benefit the most from pharmacological treatment for ADHD. […] To date, clear predictors of pharmacological ADHD treatment effect remain elusive.
  • #26
    https://link.springer.com/article/10.1007/s00787-025-02650-8
    Predictors for the pharmacological effect of ADHD medication in children and adolescents are lacking. This study examined clinically relevant factors in a large (N=638) prospective cohort reflecting real-world evidence. […] In our large naturalistic cohort, we could not identify any clinically relevant factors that reliably predict pharmacological treatment outcomes. […] Our findings support the compiled evidence that to date, distinct predictors for the treatment effect of ADHD medication have not yet been revealed. […] Given these circumstances, it is reasonable to consider a new perspective regarding which child would benefit the most from pharmacological treatment for ADHD. […] To date, clear predictors of pharmacological ADHD treatment effect remain elusive.
  • #27 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    The latter were indistinguishable from controls in these areas. […] Severity of childhood and adolescent ADHD is another factor that has been reported to predict adult impairment in the above major life domains. […] Comorbidity in childhood predicts comorbidity in later life. […] Findings are equivocal as to whether stimulant treatment impacts outcomes. […] Research has identified predictors of ADHD persistence and functional outcomes at different developmental stages. […] As a lifelong condition, ADHD may require ongoing treatment to promote optimal long-term outcome.
  • #28
    https://link.springer.com/article/10.1007/s00787-025-02650-8
    Predictors for the pharmacological effect of ADHD medication in children and adolescents are lacking. This study examined clinically relevant factors in a large (N=638) prospective cohort reflecting real-world evidence. […] In our large naturalistic cohort, we could not identify any clinically relevant factors that reliably predict pharmacological treatment outcomes. […] Our findings support the compiled evidence that to date, distinct predictors for the treatment effect of ADHD medication have not yet been revealed. […] Given these circumstances, it is reasonable to consider a new perspective regarding which child would benefit the most from pharmacological treatment for ADHD. […] To date, clear predictors of pharmacological ADHD treatment effect remain elusive.
  • #29 Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case–control study | BMJ Open
    https://bmjopen.bmj.com/content/14/7/e084203
    Children with neurodivergent traits at ages 7 and 9 years were two times as likely to experience chronic disabling fatigue at age 18 years (likely ADHD OR=2.18 (95% CI=1.33 to 3.56); p=0.002; likely autism OR=1.78 (95% CI=1.17 to 2.72); p=0.004). […] Our results indicate higher risk of chronic disabling fatigue for children with neurodivergent traits, likely linked to higher levels of inflammation. […] Children who met criteria for likely autism or ADHD showed higher frequency of chronic disabling fatigue at age 18 years in comparison to children who did not meet criteria. […] Increased inflammation, as indicated by IL-6 levels at age 9 years, provides a potential mechanistic explanation for this link, even when controlling for depression. […] Our findings call for transdiagnostic screening practices to support health and well-being during development and adolescence.
  • #30 Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case–control study | BMJ Open
    https://bmjopen.bmj.com/content/14/7/e084203
    Children with neurodivergent traits at ages 7 and 9 years were two times as likely to experience chronic disabling fatigue at age 18 years (likely ADHD OR=2.18 (95% CI=1.33 to 3.56); p=0.002; likely autism OR=1.78 (95% CI=1.17 to 2.72); p=0.004). […] Our results indicate higher risk of chronic disabling fatigue for children with neurodivergent traits, likely linked to higher levels of inflammation. […] Children who met criteria for likely autism or ADHD showed higher frequency of chronic disabling fatigue at age 18 years in comparison to children who did not meet criteria. […] Increased inflammation, as indicated by IL-6 levels at age 9 years, provides a potential mechanistic explanation for this link, even when controlling for depression. […] Our findings call for transdiagnostic screening practices to support health and well-being during development and adolescence.
  • #31 Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case–control study | BMJ Open
    https://bmjopen.bmj.com/content/14/7/e084203
    Children with neurodivergent traits at ages 7 and 9 years were two times as likely to experience chronic disabling fatigue at age 18 years (likely ADHD OR=2.18 (95% CI=1.33 to 3.56); p=0.002; likely autism OR=1.78 (95% CI=1.17 to 2.72); p=0.004). […] Our results indicate higher risk of chronic disabling fatigue for children with neurodivergent traits, likely linked to higher levels of inflammation. […] Children who met criteria for likely autism or ADHD showed higher frequency of chronic disabling fatigue at age 18 years in comparison to children who did not meet criteria. […] Increased inflammation, as indicated by IL-6 levels at age 9 years, provides a potential mechanistic explanation for this link, even when controlling for depression. […] Our findings call for transdiagnostic screening practices to support health and well-being during development and adolescence.
  • #32 Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case–control study | BMJ Open
    https://bmjopen.bmj.com/content/14/7/e084203
    Children with neurodivergent traits at ages 7 and 9 years were two times as likely to experience chronic disabling fatigue at age 18 years (likely ADHD OR=2.18 (95% CI=1.33 to 3.56); p=0.002; likely autism OR=1.78 (95% CI=1.17 to 2.72); p=0.004). […] Our results indicate higher risk of chronic disabling fatigue for children with neurodivergent traits, likely linked to higher levels of inflammation. […] Children who met criteria for likely autism or ADHD showed higher frequency of chronic disabling fatigue at age 18 years in comparison to children who did not meet criteria. […] Increased inflammation, as indicated by IL-6 levels at age 9 years, provides a potential mechanistic explanation for this link, even when controlling for depression. […] Our findings call for transdiagnostic screening practices to support health and well-being during development and adolescence.
  • #33 Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case–control study | BMJ Open
    https://bmjopen.bmj.com/content/14/7/e084203
    Children with neurodivergent traits at ages 7 and 9 years were two times as likely to experience chronic disabling fatigue at age 18 years (likely ADHD OR=2.18 (95% CI=1.33 to 3.56); p=0.002; likely autism OR=1.78 (95% CI=1.17 to 2.72); p=0.004). […] Our results indicate higher risk of chronic disabling fatigue for children with neurodivergent traits, likely linked to higher levels of inflammation. […] Children who met criteria for likely autism or ADHD showed higher frequency of chronic disabling fatigue at age 18 years in comparison to children who did not meet criteria. […] Increased inflammation, as indicated by IL-6 levels at age 9 years, provides a potential mechanistic explanation for this link, even when controlling for depression. […] Our findings call for transdiagnostic screening practices to support health and well-being during development and adolescence.
  • #34 ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity | Canadian Paediatric Society
    https://cps.ca/documents/position/adhd-etiology-diagnosis-and-comorbidity
    ADHD is a heterogeneous disorder. Because paediatricians and family physicians are the first care providers to conduct a medical assessment of children and youth with ADHD, which should always include a complete history, physical examination and consideration of differential diagnosis and possible comorbidities for this disorder, it is essential that their training equips them with the clinical skills needed to assess and manage ADHD and comorbid disorders.
  • #35 Childhood predictors of adolescent and young adult outcome in ADHD – PubMed
    https://pubmed.ncbi.nlm.nih.gov/25680235/
    Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood, but it remains unclear which childhood factors predict future outcome. […] To identify childhood predictors of ADHD outcome using both dimensional and categorical approaches. […] Of the sample, 79% continued to meet clinical criteria of ADHD in adolescence and young adulthood. Higher parent-rated ADHD symptoms and movement intensity in childhood, but not teacher-rated symptoms, predicted ADHD symptoms at follow up. […] SES and IQ emerge as potential moderators for the prognosis of ADHD. Childhood severity of ADHD symptoms, as measured by parent ratings and actigraph movement intensity, also predicts later ADHD outcome. These factors should be considered when identifying ADHD children at most risk of poor long-term outcomes and for the development of interventions to improve prognosis.
  • #36 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    The latter were indistinguishable from controls in these areas. […] Severity of childhood and adolescent ADHD is another factor that has been reported to predict adult impairment in the above major life domains. […] Comorbidity in childhood predicts comorbidity in later life. […] Findings are equivocal as to whether stimulant treatment impacts outcomes. […] Research has identified predictors of ADHD persistence and functional outcomes at different developmental stages. […] As a lifelong condition, ADHD may require ongoing treatment to promote optimal long-term outcome.
  • #37 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    The latter were indistinguishable from controls in these areas. […] Severity of childhood and adolescent ADHD is another factor that has been reported to predict adult impairment in the above major life domains. […] Comorbidity in childhood predicts comorbidity in later life. […] Findings are equivocal as to whether stimulant treatment impacts outcomes. […] Research has identified predictors of ADHD persistence and functional outcomes at different developmental stages. […] As a lifelong condition, ADHD may require ongoing treatment to promote optimal long-term outcome.
  • #38 Developmental Course of Attention Deficit Hyperactivity Disorder and its Predictors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3565715/
    To outline the key features of the developmental progression of ADHD and to consider the most prominent influences on its developmental course and outcomes. […] Presentation of ADHD and associated impairments evolve across development, as do outcome predictors. In early development, in addition to genetics, some forms of prenatal adversity increase the risk for ADHD. In preschool years, symptom severity, cognitive function, and family factors become significant predictors of school age outcomes. These continue to predict long-term outcomes in school aged children, and comorbidity emerges as another significant long-term outcome predictor at this stage. […] Presentation of ADHD and risk factors for later adversity evolve across development, which calls for developmentally-informed clinical practices.